McCabe Vision Center: Clinical Trials

1 completed. 1 Not applicable.

By phase and status

Phase	Trials	Status
Not applicable	1	Completed 1

Follow McCabe Vision Center: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Comparing Patient Satisfaction With Pataday or Bepreve Olopatadine hydrochloride 0.2%, Bepotastine besilate ophthalmic solution 1.5% - Eye Allergies	Not applicable	Completed	McCabe Vision Center	30	2011-09-01	2014-01-09

Conditions studied

Hypersensitivity (1)  ·  Pruritus (1)

Interventions

Olopatadine Hydrochloride (1)  ·  bepotastine besilate (1)

Countries

United States (1)